Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?

Al-Dasooqi N, Gibson RJ, Bowen JM, Keefe DM.

Cancer Chemother Pharmacol. 2009 Jun;64(1):1-9. doi: 10.1007/s00280-009-0984-y. Epub 2009 Mar 21. Review.

PMID:
19305997
2.

Matrix metalloproteinases and gut toxicity following cytotoxic cancer therapy.

Al-Dasooqi N.

Curr Opin Support Palliat Care. 2014 Jun;8(2):164-9. doi: 10.1097/SPC.0000000000000049. Review.

PMID:
24752198
3.

Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.

Al-Dasooqi N, Gibson RJ, Bowen JM, Logan RM, Stringer AM, Keefe DM.

Exp Biol Med (Maywood). 2010 Oct;235(10):1244-56. doi: 10.1258/ebm.2010.010082. Epub 2010 Aug 3.

PMID:
20682600
4.

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM.

Cancer Treat Rev. 2007 Aug;33(5):448-60. Epub 2007 May 15. Review.

PMID:
17507164
5.

Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.

Stringer AM, Gibson RJ, Bowen JM, Logan RM, Yeoh AS, Keefe DM.

J Support Oncol. 2007 Jun;5(6):259-67. Review.

PMID:
17624050
6.

Regimen-related gastrointestinal toxicities in cancer patients.

Sonis ST.

Curr Opin Support Palliat Care. 2010 Mar;4(1):26-30. doi: 10.1097/SPC.0b013e328335fb76. Review.

PMID:
20040879
7.

Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?

Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM.

Cancer Chemother Pharmacol. 2009 Jan;63(2):239-51. doi: 10.1007/s00280-008-0732-8. Epub 2008 Mar 20.

PMID:
18351341
8.

Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.

Gibson RJ, Keefe DM.

Support Care Cancer. 2006 Sep;14(9):890-900. Epub 2006 Apr 8. Review.

PMID:
16604351
9.

Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.

Stringer AM, Gibson RJ, Bowen JM, Keefe DM.

Curr Drug Metab. 2009 Jan;10(1):79-83. Review.

PMID:
19149515
10.

Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.

Stringer AM, Al-Dasooqi N, Bowen JM, Tan TH, Radzuan M, Logan RM, Mayo B, Keefe DM, Gibson RJ.

Support Care Cancer. 2013 Jul;21(7):1843-52. doi: 10.1007/s00520-013-1741-7. Epub 2013 Feb 10.

PMID:
23397098
11.

Mucositis and non-invasive markers of small intestinal function.

Tooley KL, Howarth GS, Butler RN.

Cancer Biol Ther. 2009 May;8(9):753-8. Epub 2009 May 19. Review.

PMID:
19276675
12.

A novel non-invasive biomarker for assessment of small intestinal mucositis in children with cancer undergoing chemotherapy.

Tooley KL, Saxon BR, Webster J, Zacharakis B, McNeil Y, Davidson GP, Butler RN.

Cancer Biol Ther. 2006 Oct;5(10):1275-81. Epub 2006 Oct 20.

PMID:
17012839
13.

Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation.

Okamoto T, Akuta T, Tamura F, van Der Vliet A, Akaike T.

Biol Chem. 2004 Nov;385(11):997-1006. Review.

PMID:
15576319
14.

Emerging drugs for chemotherapy-induced mucositis.

Keefe DM, Sonis ST, Bowen JM.

Expert Opin Emerg Drugs. 2008 Sep;13(3):511-22. doi: 10.1517/14728214.13.3.511 . Review.

PMID:
18764726
15.

Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis.

Sultani M, Stringer AM, Bowen JM, Gibson RJ.

Chemother Res Pract. 2012;2012:490804. doi: 10.1155/2012/490804. Epub 2012 Sep 2.

16.

New pharmacotherapy options for chemotherapy-induced alimentary mucositis.

Wardill HR, Bowen JM, Gibson RJ.

Expert Opin Biol Ther. 2014 Mar;14(3):347-54. doi: 10.1517/14712598.2014.874412. Epub 2014 Jan 6. Review.

PMID:
24387716
17.

Glucagon-like peptides 1 and 2: intestinal hormones implicated in the pathophysiology of mucositis.

Kissow H.

Curr Opin Support Palliat Care. 2015 Jun;9(2):196-202. doi: 10.1097/SPC.0000000000000132. Review.

PMID:
25872118
18.

Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis.

Prisciandaro LD, Geier MS, Butler RN, Cummins AG, Howarth GS.

Crit Rev Food Sci Nutr. 2011 Mar;51(3):239-47. doi: 10.1080/10408390903551747. Review.

PMID:
21390944
19.

Oral and intestinal mucositis - causes and possible treatments.

Duncan M, Grant G.

Aliment Pharmacol Ther. 2003 Nov 1;18(9):853-74. Review.

20.

Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy.

Epstein JB, Klasser GD.

Expert Opin Emerg Drugs. 2006 May;11(2):353-73. Review.

PMID:
16634706
Items per page

Supplemental Content

Write to the Help Desk